GlassScriptPhysician profile
Magda Desimone
NPI 1790998680
$1,919.28
in general payments reported to CMS, 2019-2025
19 companies · $17.53 in 2025
The $17.53 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $321 · 2022: $1,055 · 2023: $460 · 2024: $64.95 · 2025: $17.53.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $478 · Education: $64.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $477.57 |
| Education | $64.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $399.40 | 2021-2023 | |
| Incyte Corporation | $271.98 | 2021-2023 | Opzelura |
| Pfizer INC. | $218.93 | 2021-2023 | |
| Almirall LLC | $190.32 | 2022-2023 | Seysara |
| Leo Pharma INC. | $172.02 | 2021-2023 | Adbry |
| Genzyme Corporation | $123.06 | 2021-2023 | |
| Novartis Pharmaceuticals Corporation | $76.19 | 2022-2023 | |
| Lilly USA, LLC | $72.46 | 2022 | |
| Janssen Biotech, INC. | $64.95 | 2024 | Tremfya |
| E.R. Squibb & Sons, L.L.C. | $57.79 | 2023 | Sotyktu |
| Amgen INC. | $54.50 | 2023 | Otezla |
| Sun Pharmaceutical Industries INC. | $40.09 | 2023 | Absorica Ld, Winlevi |
| Regeneron Healthcare Solutions, INC. | $36.06 | 2021-2022 | |
| Arcutis Biotherapeutics, INC. | $35.66 | 2023 | |
| Biofrontera INC. | $33.17 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $22.33 | 2021 | |
| Journey Medical Corporation | $19.15 | 2022 | |
| Glaxosmithkline, LLC. | $17.53 | 2025 | Nucala |
| Dermavant Sciences, INC. | $13.69 | 2023 | Vtama |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Magda Desimone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.